Clinical Definition
OHS is characterized by:
- Obesity: BMI ≥30 kg/m²
- Chronic Hypercapnia: Elevated CO2 levels during wake
- Sleep Hypoventilation: Worsened ventilation during sleep
- Sleep Apnea: Often coexists with OSA
- Cardiopulmonary Complications: Heart failure, pulmonary hypertension
OHS affects approximately 10-20% of obese patients with sleep apnea and has significant morbidity and mortality if untreated.
Etymology & History
Reference Values & Interpretation
Normal Values
Normal individuals should not have chronic hypercapnia or significant hypoventilation, even with obesity.
Abnormal Values
OHS is diagnosed when an obese patient has daytime PaCO2 >45 mmHg with sleep-disordered breathing, indicating chronic hypoventilation.
How It's Measured
OHS is diagnosed through arterial blood gas analysis showing elevated CO2 levels, along with sleep studies demonstrating sleep-disordered breathing in obese patients.
Role in Diagnosis
OHS diagnosis requires demonstration of chronic hypercapnia in an obese patient with sleep-disordered breathing, after excluding other causes.
Role in Treatment
Treatment includes weight loss, non-invasive ventilation (often BiPAP), and management of comorbidities. Some patients may also need supplemental oxygen.
Associated Conditions
pickwickian-syndrome|chronic-hypercapnia|bipap|weight-loss
Clinical Guidelines
[{"guideline_title":"AASM Clinical Practice Guideline for OHS Treatment","guideline_link":"/clinical/guidelines/aasm-ohs-treatment/"}]
Latest Research & Updates
Recent research has focused on early detection of OHS and optimal treatment strategies, with studies showing that effective treatment can significantly improve outcomes and reduce hospitalizations.